What was the market valuation of the US gamma knife market in 2024?

The market valuation of the US gamma knife market was $140.0 Million in 2024. Read More

What is the projected market valuation for the US gamma knife market in 2035?

The projected market valuation for the US gamma knife market is $250.0 Million in 2035. Read More

What is the expected CAGR for the US gamma knife market during the forecast period 2025 - 2035?

The expected CAGR for the US gamma knife market during the forecast period 2025 - 2035 is 5.41%. Read More

Which companies are considered key players in the US gamma knife market?

Key players in the US gamma knife market include Elekta AB, Accuray Incorporated, Varian Medical Systems, Brainlab AG, MediTech, Nicolet Biomedical, Shenzhen Huikang Medical, and Stereotactic Radiosurgery. Read More

What are the primary disease indications for gamma knife treatments?

The primary disease indications for gamma knife treatments include Brain Metastasis, Cancer, Arteriovenous Malformation, Trigeminal Neuralgia, and Others. Read More

What was the market value for cancer treatment using gamma knife in 2024?

The market value for cancer treatment using gamma knife was $50.0 Million to $90.0 Million in 2024. Read More

How does the market value for brain metastasis compare to other disease indications?

The market value for brain metastasis ranged from $30.0 Million to $55.0 Million, indicating a competitive position among other disease indications. Read More

What anatomical areas are primarily targeted in gamma knife procedures?

The primary anatomical areas targeted in gamma knife procedures include the Head, Neck, and Others. Read More

What was the market value for neck treatments in 2024?

The market value for neck treatments using gamma knife was $40.0 Million to $75.0 Million in 2024. Read More

What is the anticipated growth trend for the US gamma knife market?

The anticipated growth trend for the US gamma knife market suggests a steady increase, with a projected valuation of $250.0 Million by 2035. Read More

US Gamma Knife Market

ID: MRFR/HC/51019-HCR

200 Pages

Vikita Thakur

Last Updated: February 06, 2026

US Gamma Knife Market Research Report: Size, Share, Trend Analysis By Disease Indication (Brain Metastasis, Cancer, Arteriovenous Malformation, Trigeminal Neuralgia, Others) and By Anatomy (Head, Neck, Others) - Growth Outlook & Industry Forecast 2025 To 2035

English

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Construction, BY Disease Indication (USD Million)
  1. 4.1.1 Brain Metastasis
  2. 4.1.2 Cancer
  3. 4.1.3 Arteriovenous Malformation
  4. 4.1.4 Trigeminal Neuralgia
  5. 4.1.5 Others
2. 4.2 Construction, BY Anatomy (USD Million)
  1. 4.2.1 Head
  2. 4.2.2 Neck
  3. 4.2.3 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Construction
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Elekta AB (SE)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Accuray Incorporated (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Varian Medical Systems (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Brainlab AG (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 MediTech (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Nicolet Biomedical (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Shenzhen Huikang Medical (CN)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Stereotactic Radiosurgery (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY DISEASE INDICATION
3. 6.3 US MARKET ANALYSIS BY ANATOMY
4. 6.4 KEY BUYING CRITERIA OF CONSTRUCTION
5. 6.5 RESEARCH PROCESS OF MRFR
6. 6.6 DRO ANALYSIS OF CONSTRUCTION
7. 6.7 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
8. 6.8 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
9. 6.9 SUPPLY / VALUE CHAIN: CONSTRUCTION
10. 6.10 CONSTRUCTION, BY DISEASE INDICATION, 2024 (% SHARE)
11. 6.11 CONSTRUCTION, BY DISEASE INDICATION, 2024 TO 2035 (USD Million)
12. 6.12 CONSTRUCTION, BY ANATOMY, 2024 (% SHARE)
13. 6.13 CONSTRUCTION, BY ANATOMY, 2024 TO 2035 (USD Million)
14. 6.14 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY DISEASE INDICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY ANATOMY, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Construction Market Segmentation

Construction By Disease Indication (USD Million, 2025-2035)

Brain Metastasis
Cancer
Arteriovenous Malformation
Trigeminal Neuralgia
Others

Construction By Anatomy (USD Million, 2025-2035)

Head
Neck
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”